Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Kubota Pharma, Last Fiscal Year's Undisclosed Net Income to Narrow
4596 Kubota Pharmaceutical Holdings Co., Ltd. 【IFRS】
Guidance Update ReportKubota Pharmaceutical Holdings Co., Ltd. <4596> [TSE Growth] announced a previously undisclosed earnings forecast after the market closed on February 12th (15:30). The consolidated net loss for the fiscal year ending December 2024 is expected to further decrease to loss of 1.33 billion yen (compared to a loss of 1.49 billion yen in the previous period).
Kabutan News
Guidance Update
Second Half Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jul - Dec, 2024 Prev | ー | ー | ー | ー | - | 0 | Feb 14, 2024 | IFRS |
Jul - Dec, 2024 New | 17 | -614 | -664 | -664 | -11.8 | 0 | Feb 12, 2025 | IFRS |
Revision Rate | - | - | - | - | - |
Full Year Update
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2024 Prev | ー | ー | ー | ー | - | 0 | Feb 14, 2024 | IFRS |
Dec, 2024 New | 27 | -1,289 | -1,333 | -1,333 | -23.7 | 0 | Feb 12, 2025 | IFRS |
Revision Rate | - | - | - | - | - |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Jul - Dec, 2023 | 23 | -757 | -745 | -745 | -13.4 | 0 | Feb 14, 2024 | IFRS |
Jul - Dec, 2024 Guidance | 17 | -614 | -664 | -664 | -11.8 | 0 | Feb 12, 2025 | IFRS |
YoY | -26.1% | +18.9% | +10.9% | +10.9% | +12.1% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Dec, 2022 | 8 | -2,038 | -2,016 | -2,016 | -40.9 | 0 | Feb 14, 2023 | IFRS |
Dec, 2023 | 40 | -1,504 | -1,490 | -1,490 | -26.8 | 0 | Feb 14, 2024 | IFRS |
Dec, 2024 Guidance | 27 | -1,289 | -1,333 | -1,333 | -23.7 | 0 | Feb 12, 2025 | IFRS |
YoY | -32.5% | +14.3% | +10.5% | +10.5% | +11.7% |
Related Articles
Photosynth, 76% Increase in Ordinary Profit, Update Record High for Second Consecutive Term
I-ne, 8% Increase in Ordinary Profit, Update Record High for Eighth Consecutive Term, Dividend Raised by 0.5 yen
Recovery International, 1% Increase in Ordinary Profit, Update Record High for Eighth Consecutive Term
FUSO DENTSU, Oct-Dec (1Q) Ordinary Profit Decreases by 6%
C.I. MEDICAL, 63% Increase in Ordinary Profit for The Current Fiscal Year
Moriya Transportation Engineering, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 60%, Oct-Dec Ordinary Profit Increases by 54%
ExaWizards, Apr-Dec (Cumulative 3Q) Ordinary Profit Loss Narrows, Oct-Dec Ordinary Profit Turns to Profit
BEENOS, Oct-Dec (1Q) Ordinary Profit Turns to Profit
OTANI KOGYO, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 37%, Exceeds Full-Year Plan
SERENDIP HOLDINGS, The Current Fiscal Year Ordinary Profit Revised Downward by 6%